2g00: Difference between revisions

From Proteopedia
Jump to navigationJump to search
OCA (talk | contribs)
No edit summary
OCA (talk | contribs)
No edit summary
Line 1: Line 1:
[[Image:2g00.gif|left|200px]]
{{Seed}}
[[Image:2g00.png|left|200px]]


<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2g00|  PDB=2g00  |  SCENE=  }}  
{{STRUCTURE_2g00|  PDB=2g00  |  SCENE=  }}  


'''Factor Xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-1-yl)benzamide'''
===Factor Xa in complex with the inhibitor 3-(6-(2'-((dimethylamino)methyl)-4-biphenylyl)-7-oxo-3-(trifluoromethyl)-4,5,6,7-tetrahydro-1H-pyrazolo[3,4-c]pyridin-1-yl)benzamide===




==Overview==
<!--
The bicyclic dihydropyrazolopyridinone scaffold allowed for incorporation of multiple P1 moieties with subnanomolar binding affinities for blood coagulation factor Xa. The compound 3-[6-(2'-dimethylaminomethyl-biphenyl-4-yl)-7-oxo-3-trifluoro-methyl-4,5,6 ,7-tetrahydro-pyrazolo[3,4-c]pyridine-l-yl]-benzamide 6d shows good fXa potency, selectivity, in vivo efficacy and oral bioavailability. Compound 6d was selected for further pre-clinical evaluations.
The line below this paragraph, {{ABSTRACT_PUBMED_16963264}}, adds the Publication Abstract to the page
(as it appears on PubMed at http://www.pubmed.gov), where 16963264 is the PubMed ID number.
-->
{{ABSTRACT_PUBMED_16963264}}


==About this Structure==
==About this Structure==
Line 31: Line 35:
[[Category: Protein inhibitor complex]]
[[Category: Protein inhibitor complex]]
[[Category: Serine protease]]
[[Category: Serine protease]]
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May  4 04:31:38 2008''
 
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Tue Jul 29 14:52:03 2008''